Recombinant Human TSH Increases Uptake and Effective Half-life of Radioiodine in Thyroid Hormone Secreting Metastases of Follicular Thyroid Cancer

被引：4
|
作者：
Schneider, C. [1 ]
Dietlein, M. [1 ]
Eschner, W. [2 ]
Schmidt, M. [1 ]
Kahraman, D. [1 ]
Kobe, C. [1 ]
机构：
[1] Univ Hosp Cologne, Dept Nucl Med, D-50937 Cologne, Germany
[2] Univ Cologne, Dept Nucl Med, D-50931 Cologne, Germany
来源：
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2012年 / 120卷 / 03期
关键词：
follicular thyroid cancer; thyroid hormone secreting metastases; radioiodine therapy; rhTSH; CARCINOMA; HYPERTHYROIDISM; RECOMMENDATIONS; DIAGNOSIS;
D O I：
10.1055/s-0031-1299710
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Follicular thyroid cancer with thyroid hormone secreting metastases is an extremely rare condition, with only a few cases reported world-wide. We here present the case of a 64-year-old female patient affected by follicular thyroid cancer with extensive thyroid hormone secreting metastases leading to TSH-suppression. We have also summarized the relevant diagnostic and therapeutic approaches and describe, for the first time, the effects of rhTSH-application in this rare tumor entity. In this patient, we found that rhTSH increased I-131-uptake into the thyroid hormone secreting metastases and prolonged the effective half-life of I-131. These effects of rhTSH should be considered when fixed activities of I-131 are prescribed.
引用
收藏
页码：160 / 163
页数：4
相关论文
共 50 条
  • [1] Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: A retrospective study
    Grenfell, Solveig
    Roos, Daniel
    Rijken, James
    Higgs, Braden
    Kirkwood, Ian
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (02) : 248 - 254
  • [2] Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
    Klain, Michele
    Nappi, Carmela
    De Risi, Marina
    Piscopo, Leandra
    Volpe, Fabio
    Manganelli, Mariarosaria
    Caiazzo, Elisa
    Bianco, Davide
    Schlumberger, Martin
    Cuocolo, Alberto
    DIAGNOSTICS, 2021, 11 (10)
  • [3] Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
    Bacher, Robin
    Hohberg, Melanie
    Dietlein, Markus
    Wild, Markus
    Kobe, Carsten
    Drzezga, Alexander
    Schmidt, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 631 - 637
  • [4] Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe, Carsten
    Eschner, Wolfgang
    Wild, Markus
    Rahlff, Ilka
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Dietlein, Markus
    Schicha, Harald
    NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (03) : 201 - 205
  • [5] Faster Radioiodine Washout in the Treatment of Pulmonary Metastases of Papillary Thyroid Cancer Prepared With Recombinant Human Thyroid-Stimulating Hormone
    Hung, Guang-Uei
    Ho, Minglin
    Kao, Chia-Hung
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (05) : 316 - 317
  • [6] Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
    Tsai, Hsi-Chen
    Ho, Kung-Chu
    Chen, Shih-Hsin
    Tseng, Jing-Ren
    Yang, Lan-Yan
    Lin, Kun-Ju
    Cheng, Ju-Chin
    Liou, Miaw-Jene
    DIAGNOSTICS, 2022, 12 (01)
  • [7] Radioiodinated recombinant human TSH: A novel radiopharmaceutical for thyroid cancer metastases detection
    Corsetti, F
    Chianelli, M
    Cornelissen, B
    Van de Wiele, C
    D'Alessandria, C
    Slegers, G
    Mather, SJ
    Di Mario, U
    Filetti, S
    Scopinaro, F
    Signore, A
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (01) : 57 - 63
  • [8] Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
    Tala, H.
    Robbins, R.
    Fagin, J. A.
    Larson, S. M.
    Tuttle, R. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07) : 2105 - 2111
  • [9] RhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of 131I
    Menzel, C
    Kranert, WT
    Döbert, N
    Diehl, M
    Fietz, T
    Hamscho, N
    Berner, U
    Grünwald, F
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (07) : 1065 - 1068
  • [10] Recombinant human thyroid-stimulating hormone: Use in papillary and follicular thyroid cancer
    Schlumberger, Martin
    Borget, Isabelle
    De Pouvourville, Gerard
    Pacini, Furio
    HORMONE RESEARCH, 2007, 67 : 132 - 142
12345